Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa

Tumor Biology

Volumn 22, Issue 6, 2001, Pages 383-389

  Papadopoulou, S ^a   Scorilas, A ^b   Arnogianaki, N ^a   Papapanayiotou, B ^a   Tzimogiani, A ^c   Agnantis, N ^d   Talieri, M ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c UNIVERSITY OF WEST ATTICA   (Greece)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Colon cancer; Gelatinase A; MMP 2

Indexed keywords

ANTIGEN; GELATINASE A; GELATINASE B;

ADENOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COLON ADENOCARCINOMA; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

EID: 0035685523     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050641     Document Type: Article

References (31)

1. Changing views of the role of matrix metalloproteinases in metastasis
2. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
3. Matrix metalloproteinases: Biologic activity and clinical implications
4. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors
5. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging
6. Proteolysis in human breast cancer
7. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
8. MMP-2 expression, activation and inhibition
9. r72,000 type IV collagenase in human colonic adenocarcinoma
10. Matrix metalloproteinases in colonic adenomas-adenocarcinomas
11. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
12. The expression of MMP-2 and TIMP-2 in patients with colorectal adenocarcinoma invaded to the submucosal and proper muscle layer
13. Proteolysis in human breast and colorectal cancer
14. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer
15. Messenger RNA for two type IV collagenases located in stromal cells in human colon cancer
16. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
17. Cathepsin-D and c-erbB-2 have an additive prognostic value for breast cancer patients
18. c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients
19. Predictive value of c-erbB-2 and Cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis
20. Determination of c-myc amplification and overexpression in breast cancer patients: Evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis
21. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer
22. Protein measurement with the Folin phenol reagent
23. Overexpression of matrimetalloproteine-9 in human breast cancer: A potential favorable indicator in node-negative patients
24. Expression of type IV collagenases in invasive tumor
25. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
26. Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma
27. Matrix metalloproteinase gene expression
28. Activation of fibroblast-derived matrix metalloproteinase-2 by colon cancer cells in non-contact cocultures
29. r72,000 type-IV collagenase
30. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer
31. Clinical studies with matrix metalloproteinase inhibitors